BREWIN DOLPHIN LTD - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 41 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2020$995
-11.2%
3,9550.0%0.00%
Q2 2020$1,120
+43.8%
3,9550.0%0.00%
Q1 2020$779
-60.6%
3,9550.0%0.00%
Q4 2019$1,978
-31.4%
3,9550.0%0.00%
Q3 2019$2,883
-78.4%
3,955
+28.6%
0.00%
-100.0%
Q2 2019$13,346
-21.0%
3,075
+33.4%
0.00%
-50.0%
Q1 2019$16,896
+26.6%
2,305
+30.2%
0.00%0.0%
Q4 2018$13,3461,7700.00%
Other shareholders

There were no reported owners of INTEC PHARMA LTD JERUSALEM in Q1 2019.

NameSharesValueWeighting ↓
View complete list of INTEC PHARMA LTD JERUSALEM shareholders